Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01043263
Other study ID # EN3324-201
Secondary ID
Status Completed
Phase Phase 2
First received December 18, 2009
Last updated March 13, 2015
Start date December 2009
Est. completion date June 2011

Study information

Verified date March 2015
Source Grünenthal GmbH
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the efficacy and safety of EN3324 (axomadol) in subjects with moderate to severe chronic low back pain


Description:

A phase IIB, randomized, double-blind, two-arm, multi-center, placebo-controlled, study to assess the efficacy and safety of EN3324 (axomadol) in subjects with moderate to severe chronic low back pain


Recruitment information / eligibility

Status Completed
Enrollment 236
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Are females who are participating abstinence or using a medically acceptable form of contraception or have been post-menopausal, biologically sterile, or surgically sterile for more than 1 year.

- Have been on an unchanged regimen of analgesic medication for chronic low back pain on a daily basis for at least 3 months prior to screening; subjects taking opioids must not exceed total daily doses of 90mg oral morphine equivalent

- Have a history of moderate to severe CLBP

Exclusion Criteria:

- Have evidence of or a history of alcohol and/or drug abuse

- Have pain secondary to a confirmed or suspected neoplasm

- Intend to alter their physical therapy regimen during the study. Subjects who begin or end physical therapy (either home exercises or formal therapy sessions) 2 weeks prior to screening or during the study period will be excluded from the study

- Have a history or physical examination finding, which may confound pain-related data (e.g., fibromyalgia, radiculopathy)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
EN3324 (axomadol)
twice daily dosing
Placebo
twice daily dosing

Locations

Country Name City State
United States Alleghany Pain Management, PC Altoona Pennsylvania
United States Advanced Clinical Research Institute Anaheim California
United States Orange County Clinical Trials, Inc. Anaheim California
United States Austin Diagnostic Clinic Ausitn Texas
United States Future Search Trials Ausitn Texas
United States Comprehensive Clinical Research Berlin New Jersey
United States Quest Research Institute Bingham Farms Michigan
United States Beacon Clinical Research LLC Brockton Massachusetts
United States Associated Pharmaceutical Research Center, Inc. Buena Park California
United States Center for Pain Management Rehabilitation Institute of Chicago Chicago Illinois
United States Medex Healthcare Research, Inc. Chicago Illinois
United States Catalina Research Institute, LLC Chino California
United States David Schneider, MD Cincinnari Ohio
United States Community Research Cincinnati Ohio
United States Paragon Clinical Research Inc. Cranston Rhode Island
United States Robert Wagner, MD Crestview Hills Kentucky
United States KRK Medical Research Dallas Texas
United States Avail Clinical Research DeLand Florida
United States Mountain View Clinical Research Denver Colorado
United States Prime Care Research Associates Florissant Missouri
United States Neuropsychiatric Research Center of SW Florida Fort Myers Florida
United States Paradigm Clinical Research Garden Grove California
United States Clinical Trial Network Houston Texas
United States Medex Healthcare Research Houston Texas
United States CNS Healthcare Jacksonville Florida
United States Florida Institute of Medical Research Jacksonville Florida
United States Synergy Escondido La Mesa California
United States Triwest Research Associates La Mesa California
United States Office of Danka Micheals, MD Las Vegas Nevada
United States Stephen Miller, MD Las Vegas Nevada
United States Behavioral Clinical Research, Inc. Lauderhill Florida
United States LBCCR Long Beach California
United States Pacific Institute for Med Research Los Angeles California
United States Samaritan Center for Medical Research Los Gatos California
United States North Star Medical Research, LLC Middleburg Heights Ohio
United States Synergy Research Center National City California
United States Segal Institute for Clinical Research North Miami Florida
United States Altas Orthopedics & Sports Medicine Orlando Florida
United States CNS Health Orlando Florida
United States Compass Research Orlando Florida
United States International Clinical Research Institute Inc. Overland Park Kansas
United States Four Rivers Clinical Research Paducah Kentucky
United States Matthew Doust, MD Phoenix Arizona
United States Gold Coast Research LLC. Plantation Florida
United States Finger Lakes Clinical Research Rochester New York
United States Northern California Research Sacramento California
United States Sun Research Institute San Antonio Texas
United States Medex Health Research, Inc. St. Louis Missouri
United States Sundance Clinical Research St. Louis Missouri
United States Bone, Joint & Spine Surgeons, Inc. Toledo Ohio
United States Neurology & Neruoscience Center of Ohio Toledo Ohio
United States Genova Clinical Research, Inc. Tucson Arizona
United States Paradigm Clinical Tucson Arizona
United States Visions Clinical Research Tucson Arizona
United States Quality of Life Medical & Research Center Tuscon Arizona
United States Omega Clinical Research Warwick Rhode Island
United States Integrated Clinical Trial Services Inc. West Des Moines Iowa
United States New Hanover Medical Research Wilmington North Carolina
United States The Center for Clinical Research, LLC & Carolinas Pain Institute, P.A. Winstom-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Grünenthal GmbH

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the efficacy of EN3324 (axomadol) in subjects with moderate to severe CLBP. Change from baseline [Day 0] to final visit [Day 112] No
Secondary To evaluate the safety, tolerability and efficacy of EN3324 (axomadol) in subjects with moderate to severe CLBP. Change from baseline [Day 0] to final visit [Day 112] Yes
Secondary To evaluate patient reported outcomes of EN3324 (axomadol) in subjects with moderate to severe CLBP. Change from baseline [Day 0] to final visit [Day 112] No
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3